Morgan Stanley Downgrades Physicians Realty Trust to Equal-Weight
Morgan Stanley analyst Vikram Malhorta downgrades Physicians Realty Trust (NYSE:DOC) from Overweight to Equal-Weight.
Raymond James Downgrades Physicians Realty Trust to Market Perform
Raymond James analyst Jonathan Hughes downgrades Physicians Realty Trust (NYSE:DOC) from Outperform to Market Perform.
Recap: Physicians Realty Trust Q2 Earnings
Shares of Physicians Realty Trust (NYSE:DOC) remained unaffected after the company reported Q2 results.
Quarterly Results
Earnings per share fell 3.70% year over year to $0.26, which beat the estimate of $0.09.
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
Baird Downgrades Physicians Realty Trust to Neutral, Raises Price Target to $20
Baird analyst Amanda Sweitzer downgrades Physicians Realty Trust (NYSE:DOC) from Outperform to Neutral and raises the price target from $19 to $20.
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
‘Halftime Report’ Traders Weigh In On Carparts, Chevron And More
On CNBC's "Fast Money Halftime Report," Joe Terranova said Carparts.Com Inc (NASDAQ: PRTS) is a victim of the reopening trade.